BridgeBio Pharma, Inc. Current Ratio in % from Q2 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BridgeBio Pharma, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q3 2025.
  • BridgeBio Pharma, Inc. Current Ratio for the quarter ending September 30, 2025 was 453 %, a 9.09% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

BridgeBio Pharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 453 +37.8 +9.09% Sep 30, 2025
Q2 2025 446 -22.8 -4.86% Jun 30, 2025
Q1 2025 427 -28 -6.15% Mar 31, 2025
Q4 2024 450 +1.28 +0.29% Dec 31, 2024
Q3 2024 415 -73.3 -15% Sep 30, 2024
Q2 2024 469 -17.7 -3.65% Jun 30, 2024
Q1 2024 455 -70.8 -13.5% Mar 31, 2024
Q4 2023 449 -103 -18.6% Dec 31, 2023
Q3 2023 489 -116 -19.2% Sep 30, 2023
Q2 2023 487 -148 -23.3% Jun 30, 2023
Q1 2023 526 -151 -22.3% Mar 31, 2023
Q4 2022 552 -188 -25.4% Dec 31, 2022
Q3 2022 605 -145 -19.4% Sep 30, 2022
Q2 2022 634 -181 -22.2% Jun 30, 2022
Q1 2022 677 -214 -24% Mar 31, 2022
Q4 2021 740 -226 -23.4% Dec 31, 2021
Q3 2021 750 -306 -28.9% Sep 30, 2021
Q2 2021 815 -315 -27.9% Jun 30, 2021
Q1 2021 891 Mar 31, 2021
Q4 2020 965 Dec 31, 2020
Q3 2020 1.06K Sep 30, 2020
Q2 2020 1.13K Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.